Up-regulation of phosphorylated ATM/ATR substrate/Akt expression by phenylephrine in peri-infarct myocardium in rats

Acta Cardiologica Sinica

Volumn 27, Issue 3, 2011, Pages 182-188

  Mu, Yang ^a   Li, Gang ^a   Wang, Zhi Hua ^a   Zhang, Can Jing ^b  

^a CHONGQING MEDICAL UNIVERSITY   (China)

^b Department of Function Examination   (China)

Author keywords

Ataxia telangiectasia mutated (ATM) protein; ATM and Rad3 related (ATR) protein; Myocardial infarction; Phenylephrine; Protein kinase B (Akt)

Indexed keywords

ATM PROTEIN; ATR PROTEIN; PHENYLEPHRINE; PHOSPHATE BUFFERED SALINE; PROTEIN KINASE B;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HEART INFARCTION; MALE; NONHUMAN; OPTICAL DENSITY; PERITONEAL CAVITY; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; REGULATORY MECHANISM; SHAM PROCEDURE; SPRAGUE DAWLEY RAT; UPREGULATION; WESTERN BLOTTING;

EID: 84863011240     PISSN: 10116842     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Schneider JG, Finck BN, Ren J, et al. ATM-dependent suppression of stress signaling reduces vascular disease in metabolic syndrome. Cell Metab 2006;4:377-89. (Pubitemid 44645067)
2. Kato H, Takashima S, Asano Y, et al. Identification of p32 as a novel substrate for ATMin heart. Biochem Biophys Res Commun 2008;366:885-91.
3. Bakkenist CJ, Kastan MB. DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation. Nature 2003;421:499-506. (Pubitemid 36168436)
4. Yang J, Xu ZP, Huang Y, et al. ATM and ATR: sensing DNA damage. World J Gastroenterol 2004;10:155-60. (Pubitemid 38195252)
5. Hammond EM, Dorie MJ, Giaccia AJ. ATR/ATM targets are phosphorylated by ATR in response to hypoxia and ATM in response to reoxygenation. J Biol Chem 2003;278:12207-13. (Pubitemid 36800201)
6. Halaby MJ, Hibma JC, He J, et al. ATM protein kinase mediates full activation of Akt and regulates glucose transporter 4 translocation by insulin in muscle cells. Cell Signal 2008;20:1555-63.
7. DeBosch B, Sambandam N, Weinheimer C, et al. Akt2 regulates cardiac metabolism and cardiomyocyte survival. J Biol Chem 2006;281:32841-51. (Pubitemid 46036839)
8. Du XJ, Gao XM, Kiriazis H, et al. Transgenic alpha1A-adrenergic activation limits post-infarct ventricular remodeling and dysfunction and improves survival. Cardiovasc Res 2006;71: 735-43. (Pubitemid 44848290)
9. Guo J, Sabri A, Elouardighi H, et al. Alpha1-adrenergic receptors activate AKT via a Pyk2/PDK-1 pathway that is tonically inhibited by novel protein kinase C isoforms in cardiomyocytes. Circ Res 2006;99:1367-75. (Pubitemid 44949672)
10. Rokosh DG, Simpson PC. Knockout of the alpha 1A/C-adrenergic receptor subtype: the alpha 1A/C is expressed in resistance arteries and is required to maintain arterial blood pressure. Proc Natl Acad Sci USA 2002;99:9474-9. (Pubitemid 34764638)
11. Litwin SE, Katz SE, Morgan JP, et al. Serial echocardiographic assessment of left ventricular geometry and function after large myocardial infarction in the rat. Circulation 1994; 89:345-54. (Pubitemid 24026509)
12. Chua S, Sun CK, Yen CH, et al. Autologous transplantation of shock wave-treated bone marrow-derived mononuclear cells enhances vascularization and connexin43 expression in rat dilated cardiomyopathy. Acta Cardiol Sin 2009;25:64-75.
13. ALLHAT. Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). ALLHAT Collaborative Research Group. JAMA 2000;283:1967-75.
14. Cohn JN. The Vasodilator-Heart Failure Trials (V-HeFT). Mechanistic data from the VACooperative Studies. Introduction. Circulation 1993;87:VI1-4. (Pubitemid 23164216)
15. Gonzalez-Juanatey JR, Iglesias MJ, Alcaide C, et al. Doxazosin induces apoptosis in cardiomyocytes cultured in vitro by a mechanism that is independent of alpha1-adrenergic blockade. Circulation 2003;107:127-31. (Pubitemid 36070944)
16. Mani K, Ashton AW, Kitsis RN. Taking the BAD out of adrenergic stimulation. J Mol Cell Cardiol 2002;34:709-12. (Pubitemid 35205173)
17. Lin F, Owens WA, Chen S, et al. Targeted alpha(1A)-adrenergic receptor overexpression induces enhanced cardiac contractility but not hypertrophy. Circ Res 2001;89:343-50. (Pubitemid 34132673)
18. O'Connell TD, Swigart PM, Rodrigo MC, et al. Alpha1-adrenergic receptors prevent a maladaptive cardiac response to pressure overload. J Clin Invest 2006;116:1005-15.
19. Du XJ, Fang L, Gao XM, et al. Genetic enhancement of ventricular contractility protects against pressure-overload-induced cardiac dysfunction. J Mol Cell Cardiol 2004;37:979-87. (Pubitemid 39446823)
20. Huang Y, Wright CD, Merkwan CL, et al. An alpha1A-adrenergic- extracellular signal-regulated kinase survival signaling pathway in cardiac myocytes. Circulation 2007;115:763-72. (Pubitemid 46294744)
21. Woodcock EA, Du XJ, Reichelt ME, et al. Cardiac alpha 1-adrenergic drive in pathological remodelling. Cardiovasc Res 2008;77:452-62. (Pubitemid 351197669)
22. Francis GS. Neuroendocrine activity in congestive heart failure. Am J Cardiol 1990;66:33D-9D. (Pubitemid 20352292)
23. Seeland U, Kouchi I, Zolk O, et al. Effects of diuretic treatment on cardiac and circulating RAS in chronic heart failure post-myocardial infarction in rats. Eur J Heart Fail 2003;5:241-6. (Pubitemid 37011851)